SCHEMBL2425798

SCHEMBL2425798

CCC(Nc1cc(C(=O)O)c(C)cc1C(N)=O)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 5/20 0.38
HSP90AB1 P08238 5/20 0.38
TAS1R3 Q7RTX0 2/20 0.37
TAS1R1 Q7RTX1 2/20 0.37
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 1/20 0.33
RAB9A P51151 1/20 0.33
HCAR3 P49019 3/20 0.33
NNMT P40261 1/20 0.33
GRM1 Q13255 1/20 0.32
POLB P06746 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13450313 0.93 TAS1R3 (0.39) HSP90AA1HSP90AB1TAS1R3TAS1R1KDM4E
SCHEMBL2424139 0.87 HSP90AA1 (0.46) HSP90AA1HSP90AB1KDM4EALDH1A1RAB9A
SCHEMBL29460660 0.87 HSP90AA1 (0.46) HSP90AA1HSP90AB1KDM4EALDH1A1RAB9A
SCHEMBL2426568 0.87 HSP90AA1 (0.46) HSP90AA1HSP90AB1KDM4EALDH1A1RAB9A
SCHEMBL2424142 0.87 HSP90AA1 (0.46) HSP90AA1HSP90AB1KDM4EALDH1A1RAB9A
SCHEMBL2422596 0.85 HSP90AA1 (0.46) HSP90AA1HSP90AB1TAS1R3TAS1R1KDM4E
SCHEMBL2424070 0.83 HCAR3 (0.42) HSP90AA1HSP90AB1KDM4EALDH1A1RAB9A
SCHEMBL2424072 0.83 HCAR3 (0.42) HSP90AA1HSP90AB1KDM4EALDH1A1RAB9A
SCHEMBL2423473 0.83 GRM1 (0.38) HSP90AA1HSP90AB1TAS1R3TAS1R1KDM4E
SCHEMBL2424707 0.83 HSP90AA1 (0.41) HSP90AA1HSP90AB1KDM4EALDH1A1HCAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 US disclosed
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 US disclosed
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 US disclosed
EP-2074120-B1 TROPANE COMPOUNDS EXELIXIS INC (US) 2010-03-03 EP disclosed
EP-2074120-A1 TROPANE COMPOUNDS Exelixis, Inc. (US) 2009-07-01 EP disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 US disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 US disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 US disclosed
WO-2009055077-A1 TROPANE COMPOUNDS EXELIXIS, INC. (US) 2009-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163471-A1 Tropane compounds ADRA1B, ADRA2B, ADRB2 HSP90AA1 1888/4885HSP90AB1 1352/4885TAS1R3 635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.